FIORINO, GIONATA
 Distribuzione geografica
Continente #
EU - Europa 1.895
NA - Nord America 1.579
AS - Asia 922
SA - Sud America 288
AF - Africa 22
OC - Oceania 3
Totale 4.709
Nazione #
US - Stati Uniti d'America 1.556
RU - Federazione Russa 923
SG - Singapore 436
SE - Svezia 316
CN - Cina 261
BR - Brasile 252
IE - Irlanda 234
DE - Germania 115
HK - Hong Kong 99
FR - Francia 82
GB - Regno Unito 64
UA - Ucraina 59
VN - Vietnam 50
FI - Finlandia 37
IT - Italia 32
AR - Argentina 16
CA - Canada 11
IN - India 11
BD - Bangladesh 9
IQ - Iraq 9
MX - Messico 8
TR - Turchia 8
ZA - Sudafrica 7
VE - Venezuela 6
BE - Belgio 5
CO - Colombia 5
ES - Italia 5
ID - Indonesia 5
JP - Giappone 5
EC - Ecuador 4
KZ - Kazakistan 4
PH - Filippine 4
TN - Tunisia 4
CH - Svizzera 3
EG - Egitto 3
MA - Marocco 3
NL - Olanda 3
PK - Pakistan 3
PL - Polonia 3
AL - Albania 2
AM - Armenia 2
AU - Australia 2
AZ - Azerbaigian 2
DZ - Algeria 2
JO - Giordania 2
LA - Repubblica Popolare Democratica del Laos 2
LV - Lettonia 2
NP - Nepal 2
PE - Perù 2
SA - Arabia Saudita 2
AE - Emirati Arabi Uniti 1
AG - Antigua e Barbuda 1
AO - Angola 1
AT - Austria 1
BG - Bulgaria 1
BW - Botswana 1
BY - Bielorussia 1
CL - Cile 1
CZ - Repubblica Ceca 1
GT - Guatemala 1
HN - Honduras 1
HR - Croazia 1
HU - Ungheria 1
JM - Giamaica 1
KE - Kenya 1
KG - Kirghizistan 1
KW - Kuwait 1
MY - Malesia 1
NO - Norvegia 1
NZ - Nuova Zelanda 1
OM - Oman 1
PY - Paraguay 1
RO - Romania 1
RS - Serbia 1
SI - Slovenia 1
UY - Uruguay 1
UZ - Uzbekistan 1
Totale 4.709
Città #
Moscow 283
Chandler 280
Singapore 263
Dublin 234
Ashburn 203
Dallas 160
Nyköping 133
Jacksonville 128
Beijing 108
Hong Kong 99
San Jose 62
The Dalles 53
Dearborn 45
Lancaster 39
Lauterbourg 39
Princeton 38
Los Angeles 36
Medford 36
Cambridge 35
Des Moines 31
Boardman 28
Munich 26
Frankfurt am Main 19
Turku 19
São Paulo 18
Ann Arbor 17
Buffalo 16
Ho Chi Minh City 16
Belo Horizonte 15
Tianjin 14
Jinan 13
Rio de Janeiro 13
Shenyang 13
Orem 11
Guangzhou 10
Redondo Beach 10
Brooklyn 9
San Mateo 9
Santa Clara 9
Hanoi 8
New York 8
Helsinki 7
Curitiba 6
Düsseldorf 6
London 6
Pozzuolo Martesana 6
Wilmington 6
Zhengzhou 6
Brasília 5
Brussels 5
Hebei 5
Johannesburg 5
Phoenix 5
Porto Alegre 5
Santo André 5
Washington 5
Bremen 4
Caracas 4
Da Nang 4
Messina 4
Shenzhen 4
Taizhou 4
Tokyo 4
Woodbridge 4
Atlanta 3
Biên Hòa 3
Boston 3
Cairo 3
Campinas 3
Canoas 3
Chicago 3
Council Bluffs 3
Denver 3
Fuzhou 3
Guarulhos 3
Haiphong 3
Hangzhou 3
Houston 3
Istanbul 3
Itajubá 3
João Pessoa 3
Lanzhou 3
Maceió 3
Manchester 3
Nanchang 3
Rome 3
Stockholm 3
Vancouver 3
Amman 2
Aparecida de Goiânia 2
Aracaju 2
Baghdad 2
Baku 2
Barra Mansa 2
Bogotá 2
Can Tho 2
Carapicuíba 2
Caxias do Sul 2
Changsha 2
Dhaka 2
Totale 2.817
Nome #
Effects of immunosuppression on immune response to pneumococcal vaccine in inflammatory bowel disease: a prospective study. 177
Response evaluation and safety of thiopurines in the treatment of inflammatory bowel diseases (IBD): safety and response evaluation. 158
Adalimumab in Crohn's Disease: Tips and Tricks After 5 Years of Clinical Experience 156
A Prospective Comparison Between Computerized Tomography (CT) and Magnetic Resonance (MR) in Ileo-Colonic Crohn's Disease: A Single-Center Experience. 154
Different Segmental Transit Time (TT) Through the Small Bowel May Affect Wireless Capsule (WC) Endoscopy 154
Balanced Propofol Sedation (BPS) Administered by Non-Anesthesiologists vs Midazolam Alone for Endoscopic Procedure in Patients With IBD: A Single Center Open-Label Trial 149
A prospective comparison between CT enterography and MR enterography (MRE) in ileo-colonic Crohn’s disease: a single-center experience. 149
H1N1 vaccines in a large observational cohort of patients with inflammatory bowel disease treated with immunomodulators and biologics. 147
Late-onset Crohn's disease: a comparison of disease behaviour and therapy with younger adult patients: the Italian Group for the Study of Inflammatory Bowel Disease 'AGED' study 144
Dual Targeted Therapy: a possible option for the management of refractory Inflammatory Bowel Disease 144
Emerging biologics in the treatment of inflammatory bowel disease: what is around the corner? 141
Acute Severe Colitis: Infliximab and/or Cyclosporine? 141
The PROSIT Cohort of Infliximab Biosimilar in IBD: A Prolonged Follow-up on the Effectiveness and Safety Across Italy 141
Infliximab Inhibits Mucosal Pathological Angiogenesis in Crohn's Disease 140
Familial aggregation in inflammatory bowel disease: Is it genes or environment? 138
Heat shock protein 47 is a new candidate molecule as anti-fibrotic treatment of Crohn's disease: authors' reply 137
Anti-TNF's for postoperative recurrence in Crohn's disease: the if's and how's. 135
Adalimumab in ulcerative colitis: hypes and hopes 132
Anti-TNF Therapy in Inflammatory Bowel Diseases 131
A prospective comparison between 1.5T magnetic resonance and 3T magnetic resonance in ileo-colonic Crohn’s disease: a single center experience. 126
Biological Therapy for Ulcerative Colitis: what is after Anti-TNF. 119
Comparison of two strategies for the management of postoperative recurrence in Crohn's disease patients with one clinical risk factor: A multicentre IG-IBD study 113
Postoperative recurrence of Crohn's disease and videocapsule endoscopy: it is necessary to leave no stone unturned. 100
Leukocyte traffic control: a novel therapeutic strategy for inflammatory bowel disease 97
Videocapsule Endoscopy in Portal Hypertension 97
Review article: anti-fibrotic agents for the treatment of Crohn's disease - lessons learnt from other diseases. 94
Review article: anti TNF-alpha induced psoriasis in patients with inflammatory bowel disease. 94
Influenza A (H1N1)v infection in patients with inflammatory bowel disease: a case series. 93
Infliximab therapy inhibits inflammation-induced angiogenesis in the mucosa of patients with Crohn's disease. 92
Safety of a (H1N1)V Vaccine in patients with inflammatory bowel disease treated with immunomodulators and biologicals 90
Narrow-band imaging endoscopy to assess mucosal angiogenesis in inflammatory bowel disease: a pilot study. 88
Risk of postoperative recurrence and postoperative management of Crohn's disease. 84
The bacterial sensor Triggering Receptor Expressed on Myeloid cells 2 (TREM-2) is a crucial pathogenic mediator in inflammatory bowel disease (IBD) 83
New drug delivery systems in inflammatory bowel disease: MMX and taylored delivery to the gut. 81
The efficacy of shortening the dosing interval to once every six weeks in Crohn's patients losing response to maintenance dose of infliximab. 80
MRI in Crohn's disease-current and future clinical applications. 76
Mucosal healing in Ulcerative Colitis: Where do we Stand? 70
Review article: Causative factors and the clinical management of patients with Crohn's disease who lose response to anti-TNF-α therapy. 68
Follow-up evaluation and management of anemia in inflammatory bowel disease: A study by the Italian Group for Inflammatory Bowel Diseases (IG-IBD) 68
Use of biosimilars in inflammatory bowel disease: Statements of the Italian Group for Inflammatory Bowel Disease. 66
null 37
null 31
null 27
Totale 4.742
Categoria #
all - tutte 15.561
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 15.561


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/202129 0 0 0 0 0 0 0 0 0 0 0 29
2021/2022246 1 20 3 12 5 1 8 8 1 36 54 97
2022/2023797 73 71 42 102 50 80 15 34 308 10 8 4
2023/2024189 14 29 7 48 20 30 3 13 2 16 0 7
2024/2025729 5 6 25 49 26 28 24 135 204 40 51 136
2025/20262.084 54 158 125 84 158 552 269 294 241 90 23 36
Totale 4.742